Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Catumaxomab in Gastric Adenocarcinoma After Neoadjuvant Chemotherapy
NCT00464893Phase 2Completed
- Sponsor
- Neovii Pharmaceuticals
- Start
- Apr 2007
- Primary completion
- Apr 2009
- Modality
- Bispecific Antibodies
- Countries
- 4
01
Overview
A Phase 2 trial of catumaxomab in gastric adenocarcinoma, sponsored by Neovii Pharmaceuticals. Started Apr 2007; status: completed.
02
Drugs
catumaxomab
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT00464893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00464893.